Directory
>
Steven Leili
Steven Leili
Executive Director | Entrada Therapeutics
United States
Steven Leili
Summary
Steven Leili is a seasoned drug development professional with over 30 years of experience in toxicology, specializing in both small molecules and biologics. Currently serving as the Executive Director of Toxicology and Product Development at Entrada Therapeutics, he has a proven record of advancing drug candidates from discovery through to life-cycle management. His expertise spans various disease areas including anti-infectives and CNS, showcasing his versatility and depth of knowledge in the field. Steven has successfully led multidisciplinary project teams and has established strong relationships at the executive level, driving business growth through innovative strategies. His academic background includes a PhD in Animal Sciences and a Master's in Toxicology, underscoring his strong foundation in scientific research. In addition to his technical skills, he has a deep understanding of regulatory submissions and compliance, making him a key figure in the drug development process. He is passionate about fostering collaboration across functions to achieve common goals in pharmaceutical development.
Steven Leili
Work Experience
Executive Director at
Entrada Therapeutics
January 2023 - Present
Sr. Director, Toxicology, Product Development at
Entrada Therapeutics
June 2021 - Present
Executive Director at
Abbvie
May 2020 - April 2021
Research Fellow/Director/Executive Director at
Forest Laboratories (now Allergan)
December 2007 - May 2020
Study Director/Project Non-clinical Representative at
Bristol Myers Squibb
December 1987 - December 2007
Steven Leili
Education
Montclair State University, Bachelor Of Science - Bs
Rutgers University, Doctor Of Philosophy - Phd
St. John's University (New York City), Master's Degree
Frequently Asked Questions about Steven Leili
What is Steven Leili email address?
Steven Leili's primary email address is ******@entradatx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Steven Leili work for?
Steven Leili is a Executive Director at Entrada Therapeutics, a company specializing in Commercial physical research.
Where Steven Leili graduated from?
Steven Leili holds a degree in Biology from Montclair State University.
How can I directly contact Steven Leili?
To contact Steven Leili directly, you can use the email address ******@entradatx.com. Complete contact information is available upon registration with Muraena.
Who is Steven Leili?
Steven Leili is a seasoned drug development professional with over 30 years of experience in toxicology, specializing in both small molecules and biologics. Currently serving as the Executive Director of Toxicology and Product Development at Entrada Therapeutics, he has a proven record of advancing drug candidates from discovery through to life-cycle management. His expertise spans various disease areas including anti-infectives and CNS, showcasing his versatility and depth of knowledge in the field. Steven has successfully led multidisciplinary project teams and has established strong relationships at the executive level, driving business growth through innovative strategies. His academic background includes a PhD in Animal Sciences and a Master's in Toxicology, underscoring his strong foundation in scientific research. In addition to his technical skills, he has a deep understanding of regulatory submissions and compliance, making him a key figure in the drug development process. He is passionate about fostering collaboration across functions to achieve common goals in pharmaceutical development.
Steven`s contact details
******@entradatx.com
Colleagues
Vice President
Executive Director, FP&A
Vice President, Head of Cardiovascular and Neuromuscular & Cardiovascular Therapeutics
Chief Financial Officer and Treasurer
Board Member
Co-Founder & Vice President, Discovery Research
Vice President | Head of CMC
President Research And Development at Entrada Therapeutics
President and Chief Operating Officer
VP, Program Governance & Portfolio Management